SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Millennium Pharmaceuticals, Inc. (MLNM) -- Ignore unavailable to you. Want to Upgrade?

To: Mike who wrote (1917)10/29/2003 4:51:37 AM
From: Icebrg  Read Replies (2) | Respond to of 3044
 
>>This just does not smell right.>>

It does as a matter of fact smell perfectly right. From Bayer's point of view - in their desperate financial situation - hanging on to 300 mUSD worth of Millennium shares made little to no sense. Which they have now aptly demonstrated. The sale is a reflection of Bayer's circumstances, not Millennium's.

Erik



To: Mike who wrote (1917)10/29/2003 5:22:02 AM
From: nigel bates  Respond to of 3044
 
why would Bayer not be required to make both statements in the same press release?

Why on earth would it ?
To find something 'dirty' in this is approaching 'X-Files' conspiracy mindset.

As per Bayer:

The approximately 19.8 million shares (about 6.6 percent of Millennium's share capital) were sold in a block trade to the investment bank CSFB for resale...


HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News